ААР — Американская академия педиатрии (American Academy of Pediatrics)
ABC — алгоритм неотложной помощи «дыхательные пути-дыхание-кровообращение» (Airways-Breathing-Circulation)
АВСА3 — белковый член АТФ-связывающей кассеты АЗ
АВСВ11 — ген АТФ-связывающей кассеты, 11-й член подсемейства В (ATP-binding cassette, subfamily В member 11)
АВСВ4 — ген АТФ-связывающей кассеты, 4-й член подсемейства В (ATP-binding cassette 4 gene)
АВСС2 — ген, кодирующий 2-й член подсемейства С ABCDE — алгоритм неотложной помощи «дыхательные пути-дыхание-кровообращение-неврологический статус-внешний вид» (Airways-Breathing-Circulation-Disability-Exposure)
ABCG5/G8 — гетеродимер переносчика АТФ-связывающей кассеты ABCG5 и ABCG8 (Th eheterodimer of ATP-binding cassette transporter ABCG5 and ABCG8)
AC — до еды (при назначениях) — ante cibum
АСЕР — Американская коллегия врачей неотложной помощи (American College of Emergency Physicians)
ACOG — Американская коллегия акушеров и гинекологов (American College of Obstetricians and Gynecologists)
AHA — Американская кардиологическая ассоциация (American Heart Association)
AIS — аденокарцинома in situ (adenocarcinoma in situ)
ALTE — очевидное опасное для жизни событие (apparent life-threatening event)
APLS — курсы расширенных реанимационных мероприятий в педиатрии, спонсируемые Американской академией педиатрии и Американской коллегией врачей неотложной помощи (Advanced Pediatric Life Support)
AUC — площадь под фармакокинетической кривой (area under the curve)
AVPU — шкала для оценки уровня сознания («в ясном сознании»; «реакция на вербальные раздражители»; «реакция на боль»; «без сознания») (alert, verbal, pain, unresponsive)
ABCC2 - АТФ-связывающих кассет (ATP-binding cassette sub-family C member 2)
mTOR — мишень рапамицина в клетках млекопитающих (mammalian target ofrapamycin)
NB! — важно, обратить внимание (Nota bene)
NCI — Национальный институт рака (National Cancer Institute)
NICE — Национальный институт здоровья и клинического совершенствования (качества медицинской помощи) Великобритании (National Institute for Health and Clinical Excellence)
NK — естественные клетки-киллеры (natural killer)
NMDA — N-метил-D-аспартат (N-methyl-D-aspartate)
NMDA — N-метил-D-аспартатные рецепторы
NNT — число больных, которых необходимо пролечить, чтобы достичь какого-то указанного эффекта (Number Need to Treatment)
OR — отношение шансов (odds ratio)
paCO2 — парциальное давление углекислого газа в артериальной крови
PALS — курсы расширенных реанимационных мероприятий в педиатрии (Pediatric Advanced Life Support)
PANDAS — аутоиммунное нейропсихиатрическое расстройство в детском возрасте, ассоциированное со стрептококковой инфекцией (Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection)
PANS — острый нейропсихиатрический синдром в детском возрасте (Pediatric acute-onset neuropsychiatric syndrome)
paO2 — парциальное давление кислорода в артериальной крови
PAS — фуксинсернистая кислота, реактив Шиффа (periodic acid-Shiff)
PC — после еды (при назначениях) — post cibum рСO2 — парциальное давление углекислого газа PCSK-9 — пропротеиновая конвертаза субтилизин-кексинового типа 9 (proprotein convertase subtilisin/kexin type 9)
PD — плотность мощности (power density)
PD-1 — программируемая клеточная смерть 1 (англ. programmed cell death 1)
PFAPA — периодическая лихорадка с афтозным стоматитом, фарингитом и лимфаденитом (Periodic Fevers with Aphthous stomatitis, Pharyngitis and Adenitis)
PIM — показатель летального исхода у детей (Pediatric Index of Mortality)
piO2 — парциальное давление кислорода
во вдыхаемом воздухе
рО2 — парциальное давление кислорода
POLG — субъединица ДНК-полимеразы у
POP — пролапс тазовых органов (pelvic organ prolapse) POP-Q — количественная оценка пролапса тазовых органов (Pelvic Organ Prolapse Quantification)
PRISA II — оценка риска госпитализации у детей II (Pediatric Risk of Admission)
PRISM — риск летального исхода у детей (Pediatric Risk of Mortality)
PRN — при (по) необходимости (Pro re nata — при возникновении обстоятельств)
PRSS — ген сериновой протеазы
PS. — примечание (Post scriptum)
PUVA-терапия — псорален-ультрафиолет А-терапия (psoralen and ultraviolet А)
Q#H — каждые # часов (при назначениях) — quaque... hora
QAM — каждое утро (при назначениях) — quaque ante meridiem
QPM — каждый вечер (при назначениях) — quaque post meridiem
RAG — ген, активирующий рекомбиназу
REMS — Программа по оценке и снижению риска (Risk Evaluation and Mitigation Strategy)
RePEAT — пересмотренный инструмент для оценки педиатрической неотложной медицинской помощи (Revised Pediatric Emergency Assessment Tool)
RF — ревматоидный фактор
Rh — резус(-фактор)
Rh«+» — резус-положительный
Rh«-» — резус-отрицательный
ROCA — Алгоритм риска развития рака яичников (Risk of Ovarian Cancer Algorithm)
ROHHAD — быстро развивающееся ожирение с дисфункцией гипоталамуса, гиповентиляцией и спонтанной дисрегуляцией (rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation)
ROMA — Алгоритм риска наличия злокачественной опухоли яичника (Risk of Ovarian Malignancy Algorithm)
RR — относительный риск (relative risk или risk ratio)
RW — реакция Вассермана (reaction of Wassermann)
SaO2 — сатурация артериальной крови кислородом
SatO2 — насыщение крови кислородом
SCJ — зона перехода плоского эпителия в цилиндрический (Scuamocolumnar Junction)
ScvO2 — насыщение кислородом центральной венозной крови (central venous oxygen saturation)
SD — стандартное отклонение (standart deviation) SEER — эпидемиология эпиднадзора и данных о конечных результатах (Surveillance Epidemiology and End Result)
SFTPA — ген сурфактантного белка A
SFTPB — ген сурфактантного белка В
SFTPC — ген сурфактантного белка С
SILS — хирургия единого лапароскопического доступа (single-incision laparoscopic surgery)
В ходе подготовки статей по доброкачественным образованиям матки и яичников в гинекологии для пользователей сайта МедУнивер использованы труды следующих авторов:
Alessandri F, Lijoi D, Mistrangelo E, et al: Randomized study of laparoscopic versus minilaparotomic myomectomy for uterine myomas. J Minim Invasive Gynecol 13(2):92, 2006
Alyeshmerni D, Banovac F, Pehlivanova M, et al: Resolution of hydronephrosis after uterine artery embolization for fibroids. J Vasc Interv Radiol 22(6):865, 2011
Ambat S, Mittal S, Srivastava DN, et al: Uterine artery embolization versus laparoscopic occlusion of uterine vessels for management of symptomatic uterine fibroids. Int J Gynaecol Obstet 105(2):162, 2009
American College of Obstetricians and Gynecologists: Alternatives to hysterectomy in the management of leiomyomas. Practice Bulletin No. 96, August 2008, Reaffirmed 2016
American Society for Reproductive Medicine: Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertil Steril 108(3):416, 2017
Anteby SO, Yarkoni S, Ever Hadani P: The effect of a prostaglandin synthetase inhibitor, indomethacin, on excessive uterine bleeding. Clin Exp Obstet Gynecol 12(3-4):60, 1985
Antila-L?ngsj? R, M?enp?? JU, Huhtala H, et al: Comparison of transvaginal ultrasound and saline contrast sonohysterography in evaluation of cesarean scar defect: a prospective cohort study. Acta Obstet Gynecol Scand 97(9):1130, 2018
Archer DF, Stewart EA, Jain RI, et al: Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study. Fertil Steril 108(1):152, 2017
Arnold A, Ketheeswaran A, Bhatti M, et al: A prospective analysis of hysteroscopic morcellation in the management of intrauterine pathologies. J Minim Invasive Gynecol 23(3):435, 2016
Baird DD, Dunson DB, Hill MC, et al: High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188(1):100, 2003
Baird DD, Saldana TM, Shore DL, et al: A single baseline ultrasound assessment of fibroid presence and size is strongly predictive of future uterine procedure: 8-year follow-up of randomly sampled premenopausal women aged 35–49 years. Hum Reprod 30(12):2936, 2015
Barnas E, Ksi??ek M, Ra? R, et al: Benign metastasizing leiomyoma: a review of current literature in respect to the time and type of previous gynecological surgery. PLoS One 12(4):e0175875, 2017
Bayer HealthCare Pharmaceuticals: Mirena (levonorgestrel-releasing intrauterine system). Highlights of prescribing information, 2017. Available at: https://labeling.bayerhealthcare.com/html/products/pi/Mirena_PI.pdf Accessed September 9, 2018
Bazot M, Cortez A, Darai E, et al: Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod 16(11):2427, 2001
Berman JM, Guido RS, Garza Leal JG, et al: Three-year outcome of the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas. J Minim Invasive Gynecol 21(5):767, 2014
Bhave Chittawar P, Franik S, Pouwer AW, et al: Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev 10:CD004638, 2014
Bij de Vaate AJ, Br?lmann HA, van der Voet LF, et al: Ultrasound evaluation of the cesarean scar: relation between a niche and postmenstrual spotting. Ultrasound Obstet Gynecol 37(1):93, 2011
Bird CC, McElin TW, Manalo-Estrella P: The elusive adenomyosis of the uterus—revisited. Am J Obstet Gynecol 112(5):583, 1972
Bisceglia M, Galliani CA, Pizzolitto S, et al: Leiomyomatosis peritonealis disseminata: report of 3 cases with extensive review of the literature. Adv Anat Pathol 21(3):201, 2014
Bonneau C, Thomassin-Naggara I, Dechoux S, et al: Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors. Acta Obstet Gynecol Scand 93(3):261, 2014
Bratby MJ, Hussain FF, Walker WJ: Outcomes after unilateral uterine artery embolization: a retrospective review. Cardiovasc Intervent Radiol 31(2):254, 2008
Broekmans FJ: GnRH agonists and uterine leiomyomas. Human Reprod 11(Suppl 3):3, 1996
Brucker SY, Hahn M, Kraemer D, et al: Laparoscopic radiofrequency volumetric thermal ablation of fibroids versus laparoscopic myomectomy. Int J Gynaecol Obstet 125(3):261, 2014
Buckley VA, Nesbitt-Hawes EM, Atkinson P, et al: Laparoscopic myomectomy: clinical outcomes and comparative evidence. J Minim Invasive Gynecol 22(1):11, 2015
Bulun SE, Simpson ER, Word RA: Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. J Clin Endocrinol Metab 78(3):736, 1994
Cantuaria GH, Angioli R, Frost L, et al: Comparison of bimanual examination with ultrasound examination before hysterectomy for uterine leiomyoma. Obstet Gynecol 92(1):109, 1998
Carlson KJ, Miller BA, Fowler FJ Jr: The Maine Women's Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol 83(4):566, 1994
Carr BR, Marshburn PB, Weatherall PT, et al: An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial. J Clin Endocrinol Metab 76(5):1217, 1993
Carr BR, Stewart EA, Archer DF, et al: Elagolix alone or with add-back therapy in women with heavy menstrual bleeding and uterine leiomyomas: a randomized controlled trial. Obstet Gynecol 132(5):1252, 2018
Casini ML, Rossi F, Agostini R, et al: Effect of the position of fibroids on fertility. Gynecol Endocrinol 22:106, 2006
Chen CL, Liu P, Zeng BL, et al: Intermediate and long term clinical effects of uterine arterial embolization in treatment of adenomyosis. Zhonghua Fu Chan Ke Za Zhi 41(10):660, 2006
Chen R, Keserci B, Bi H, et al: The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China. J Ther Ultrasound 4(27):1, 2016
Christopoulos G, Vlismas A, Salim R, et al: Fibroids that do not distort the uterine cavity and IVF success rates: an observational study using extensive matching criteria. BJOG 124(4):615, 2017
Chudnoff SG, Berman JM, Levine DJ, et al: Outpatient procedure for the treatment and relief of symptomatic uterine myomas. Obstet Gynecol 121(5): 1075, 2013
Cooper JM, Brady RM: Late complications of operative hysteroscopy. Obstet Gynecol Clin North Am 27(2):367, 2000
Coutinho EM, Gon?alves MT: Long-term treatment of leiomyomas with gestrinone. Fertil Steril 51(6):939, 1989
Dariushnia SR, Nikolic B, Stokes LS, et al: Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. J Vasc Interv Radiol 25(11):1737, 2014
de Bruijn AM, Ankum WM, Reekers JA, et al: Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. Am J Obstet Gynecol 215(6):745. e1, 2016
de Bruijn AM, Smink M, Lohle PN, et al: Uterine artery embolization for the treatment of adenomyosis: a systematic review and meta-analysis. J Vasc Interv Radiol 82(12):1629, 2017
De Leo V, la Marca A, Morgante G: Short-term treatment of uterine fibromyomas with danazol. Gynecol Obstet Invest 47(4):258, 1999
DeWaay DJ, Syrop CH, Nygaard IE, et al: Natural history of uterine polyps and leiomyomata. Obstet Gynecol 100(1):3, 2002
Donnez J, Donnez O, Matule D, et al: Long-term medical management of uterine fibroids with ulipristal acetate. Fertil Steril 105(1):165, 2016
Donnez J, Hervais Vivancos B, Kudela M, et al: A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy. Fertil Steril 79(6):1380, 2003
Donnez J, Jadoul P: What are the implications of myomas on fertility? A need for a debate? Human Reprod 17(6):1424, 2002
Donnez J, Tatarchuk TF, Bouchard P, et al: Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 366(5):409, 2012a
Donnez J, Tomaszewski J, V?zquez F, et al: Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med 366(5):421, 2012b
Eder S, Baker J, Gersten J, et al: Efficacy and safety of oral tranexamic acid in women with heavy menstrual bleeding and fibroids. Womens Health (Lond Engl) 9(4):397, 2013
Edwards RD, Moss JG, Lumsden MA, et al: Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 356(4):360, 2007
Emanuel MH, Wamsteker K, Hart AA, et al: Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding. Obstet Gynecol 93 (5 Pt 1):743, 1999
Engel G, Rushovich AM: True uterine diverticulum. A partial m?llerian duct duplication? Arch Pathol Lab Med 108(9):734, 1984
Englund K, Blanck A, Gustavsson I, et al: Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment. J Clin Endocrinol Metab 83(11):4092, 1998
European Medicines Agency: Esmya. 2018. Available at: https://www.ema.europa.eu/en/medicines/human/referrals/esmya Accessed November 10, 2018
Friedman AJ, Daly M, Juneau-Norcross M, et al: Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin “add-back” for 2 years. Hum Reprod 9(9):1618, 1994
Friedman AJ, Hoffman DI, Comite F, et al: Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group. Obstet Gynecol 77(5):720, 1991
Froeling V, Meckelburg K, Schreiter NF, et al: Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. Eur J Radiol 82(12):2265, 2013
Glasser MH, Heinlein PK, Hung YY: Office endometrial ablation with local anesthesia using the HydroThermAblator system: comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years. J Minim Invasive Gynecol 16(6):700, 2009
Goodwin SC, Bradley LD, Lipman JC, et al: Uterine artery embolization versus myomectomy: a multicenter comparative study. Fertil Steril 85(1):14, 2006
Griffin L, Feinglass J, Garrett A, et al: Postoperative outcomes after robotic versus abdominal myomectomy. JSLS 17(3):407, 2013
Gupta JK, Sinha A, Lumsden MA, et al: Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev 12:CD005073, 2014
Hald K, Noreng HJ, Istre O, et al: Uterine artery embolization versus laparoscopic occlusion of uterine arteries for leiomyomas: long-term results of a randomized comparative trial. J Vasc Interv Radiol 20(10):1303, 2009
Hanafi M: Predictors of leiomyoma recurrence after myomectomy. Obstet Gynecol 105(4):877, 2005
Harmon QE, Baird DD: Use of depot medroxyprogesterone acetate and prevalent leiomyoma in young African American women. Hum Reprod 30(6):1499, 2015
Hart R, Moln?r BG, Magos A: Long term follow up of hysteroscopic myomectomy assessed by survival analysis. BJOG 106(7):700, 1999
Hehenkamp WJ, Volkers NA, Birnie E, et al: Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Cardiovasc Intervent Radiol 29(2):179, 2006
Hehenkamp WJ, Volkers NA, Birnie E, et al: Symptomatic uterine fibroids: treatment with uterine artery embolization or hysterectomy—results from the randomized clinical Embolisation versus Hysterectomy (EMMY) trial. Radiology 246(3):823, 2008
Hehenkamp WJ, Volkers NA, Broekmans FJ, et al: Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod 22(7):1996, 2007
Hehenkamp WJ, Volkers NA, Donderwinkel PF, et al: Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial. Am J Obstet Gynecol 193(5):1618, 2005
Hindley J, Gedroyc WM, Regan L, et al: MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol 183(6):1713, 2004
Homer J, Saridogan E: Uterine artery embolization for fibroids is associated with an increase risk of miscarriage. Fertil Steril 94(1):324, 2010
Ikhena DE, Bulun SE: Literature review on the role of uterine fibroids in endometrial function. Reprod Sci 25(5):635, 2018
Ishikawa H, Ishi K, Serna VA, et al: Progesterone is essential for maintenance and growth of uterine leiomyomata. Endocrinology 151(6):2433, 2010
Iverson RE Jr, Chelmow D, Strohbehn K, et al: Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas. Obstet Gynecol 88(3):415, 1996
Jin C, Hu Y, Chen X, et al: Laparoscopic versus open myomectomy: a meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 145(1):14, 2009
Juhasz-B?ss I, Jungmann P, Radosa J, et al: Two novel classification systems for uterine fibroids and subsequent uterine reconstruction after myomectomy. Arch Gynecol Obstet 295(3):675, 2017
Keltz J, Levie M, Chudnoff S: Pregnancy outcomes after direct uterine myoma thermal ablation: review of the literature. J Minim Invasive Gynecol 24(4):538, 2017
Kim HS, Baik JH, Pham LD, et al: MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol 18(8):970, 2011
Klebanoff J, Makai GE, Patel NR, et al: Incidence and predictors of failed second-generation endometrial ablation. Gynecol Surg 14(1):26, 2017
Kriplani A, Awasthi D, Kulshrestha V, et al: Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma. Int J Gynaecol Obstet 116(1):35, 2012
Kriplani A, Srivastava A, Kulshrestha V, et al: Efficacy of ormeloxifene versus oral contraceptive in the management of abnormal uterine bleeding due to uterine leiomyoma. J Obstet Gynaecol Res 42(12):1744, 2016
Lasmar RB, Barrozo PR, Dias R, et al: Submucous fibroids: a new presurgical classification to evaluate the viability of hysteroscopic surgical treatment— preliminary report. J Minim Invasive Gynecol 12(4):308, 2005
Laughlin-Tommaso S, Barnard EP, AbdElmagied AM, et al: FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery. Am J Obstet Gynecol 220(2):174.e1, 2019
Lee NC, Dicker RC, Rubin GL, et al: Confirmation of the preoperative diagnoses for hysterectomy. Am J Obstet Gynecol 150(3):283, 1984
Letterie GS, Coddington CC, Winkel CA, et al: Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up. Fertil Steril 51(6):951, 1989
Levgur M, Abadi MA, Tucker A: Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol 95(5):688, 2000
Levy G, Dehaene A, Laurent N, et al: An update on adenomyosis. Diagn Interv Imaging 94(1):3, 2013
Liang E, Brown B, Rachinsky M: A clinical audit on the efficacy and safety of uterine artery embolisation for symptomatic adenomyosis: results in 117 women. Aust N Z J Obstet Gynaecol 58(4):454, 2018
Loffer FD: Improving results of hysteroscopic submucosal myomectomy for menorrhagia by concomitant endometrial ablation. J Minim Invasive Gynecol 12(3):254, 2005
Longinotti MK, Jacobson GF, Hung YY, et al: Probability of hysterectomy after endometrial ablation. Obstet Gynecol 112(6):1214, 2008
Lukes AS, Moore KA, Muse KN, et al: Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 116(4):865, 2010
Ma G, Miao Q, Liu X, et al: Different surgical strategies of patients with intravenous leiomyomatosis. Medicine (Baltimore) 95(37):e4902, 2016
Machtinger R, Inbar Y, Cohen-Eylon S, et al: MR-guided focus ultrasound (MRgFUS) for symptomatic uterine fibroids: predictors of treatment success. Hum Reprod 27(12):3425, 2012
Maheshwari A, Gurunath S, Fatima F, et al: Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes. Hum Reprod Update 18(4):374, 2012
Mokoroinen L, Ylikorkala O: Primary and myoma-associated menorrhagia: role of prostaglandins and effects of ibuprofen. BJOG 93(9):974, 1986
Manyonda IT, Bratby M, Horst JS, et al: Uterine artery embolization versus myomectomy: impact on quality of life—results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) Trial. Cardiovasc Intervent Radiol 35(3):530, 2012
Mara M, Kubinova K, Maskova J, et al: Uterine artery embolization versus laparoscopic uterine artery occlusion: the outcomes of a prospective, nonrandomized clinical trial. Cardiovasc Intervent Radiol 35(5):1041, 2012
Marshall LM, Spiegelman D, Barbieri RL, et al: Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 90(6):967, 1997
Mazzon I, Favilli A, Grasso M, et al: Predicting success of single step hysteroscopic myomectomy: a single centre large cohort study of single myomas. Int J Surg 22:10, 2015
McCausland AM, McCausland VM: Depth of endometrial penetration in adenomyosis helps determine outcome of rollerball ablation. Am J Obstet Gynecol 174(6):1786, 1996
Mengerink BB, van der Wurff AA, ter Haar JF, et al: Effect of undiagnosed deep adenomyosis after failed NovaSure endometrial ablation. J Minim Invasive Gynecol 22(2):239, 2015
Miettinen M, Felisiak-Golabek A, Wasag B, et al: Fumarase-deficient uterine leiomyomas: an immunohistochemical, molecular genetic, and clinicopathologic study of 86 cases. Am J Surg Pathol 40(12):1661, 2016
Mindjuk I, Trumm CG, Herzog P, et al: MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre. Eur Radiol 25(5):1317, 2015
Mizutani T, Sugihara A, Nakamuro K, et al: Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate). J Clin Endocrinol Metab 83(4):1253, 1998
Moss J, Christie A: Uterine artery embolization for heavy menstrual bleeding. Womens Health (Lond) 12(1):71, 2016
Moss JG, Cooper KG, Khaund A, et al: Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG 118(8):936, 2011
Muneyyirci-Delale O, Chandrareddy A, Mankame S, et al: Norethindrone acetate in the medical management of adenomyosis. Pharmaceuticals 5(10):1120, 2012
Munro MG, Critchley HO, Fraser IS, et al: The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet 143(3):393, 2018
Mutter GL, Bergeron C, Deligdisch L, et al: The spectrum of endometrial pathology induced by progesterone receptor modulators. Mod Pathol 21(5):591, 2008
Naftalin J, Hoo W, Pateman K, et al: How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic. Hum Reprod 27(12):343, 2012
Olufowobi O, Sharif K, Papaionnou S, et al: Are the anticipated benefits of myomectomy achieved in women of reproductive age? A 5-year review of the results at a UK tertiary hospital. J Obstet Gynaecol 24(4):434, 2004
Ono Y, Hidaka T, Fukuta K, et al: A case of myomatous erythrocytosis syndrome associated with a large uterine leiomyoma. Case Rep Obstet Gynecol 2014:602139, 2014
Osuga Y, Enya K, Kudou K, et al: Oral gonadotropin-releasing hormone antagonist relugolix compared with leuprorelin injections for uterine leiomyomas: a randomized controlled trial. Obstet Gynecol 133(3):423, 2019
Osuga Y, Fujimoto-Okabe H, Hagino A: Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study. Fertil Steril 108(4):673, 2017
Palomba S, Affinito P, Tommaselli GA, et al: A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata. Fertil Steril 70(1):111, 1998
Palomba S, Orio F Jr, Russo T, et al: Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood, and quality of life. Fertil Steril 82(2):480, 2004
Palomba S, Zupi E, Russo T, et al: A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: short-term outcomes. Fertil Steril 88(4):942, 2007
Park MJ, Kim YS, Rhim H, et al: Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy. J Vasc Interv Radiol 25(2):231, 2014
Parker WH, Einarsson J, Istre O, et al: Risk factors for uterine rupture after laparoscopic myomectomy. J Minim Invasive Gynecol 17(5):551, 2010
Parker WH, Fu YS, Berek JS: Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83(3):414, 1994
Parsanezhad ME, Azmoon M, Alborzi S, et al: A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril 93(1):192, 2010
Parsons JE, Lau MP, Martin PJ, et al: Pilot study of the Mirabilis System prototype for rapid noninvasive uterine myoma treatment using an ultrasound-guided volumetric shell ablation technique. J Minim Invasive Gynecol 24(4):579, 2017
Philip CA, Le Mitouard M, Maillet L, et al: Evaluation of NovaSure global endometrial ablation in symptomatic adenomyosis: a longitudinal study with a 36 month follow-up. Eur J Obstet Gynecol Reprod Biol 227:46, 2018
Pop L, Suciu ID, Oprescu D, et al: Patency of uterine wall in pregnancies following assisted and spontaneous conception with antecedent laparoscopic and abdominal myomectomies—a difficult case and systematic review. J Matern Fetal Neonatal Med 21:1, 2018
Popovic M, Puchner S, Berzaczy D, et al: Uterine artery embolization for the treatment of adenomyosis: a review. J Vasc Interv Radiol 22(7):901, 2011
Preutthipan S, Herabutya Y: Hysteroscopic rollerball endometrial ablation as an alternative treatment for adenomyosis with menorrhagia and/or dysmenorrhea. J Obstet Gynaecol Res 36(5):1031, 2010
Pritts EA, Parker WH, Olive DL: Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 91(4):1215, 2009
Pron G: Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) treatment of symptomatic uterine fibroids: an evidence-based analysis. Ont Health Technol Assess Ser 15(4):1, 2015
Qin J, Yang T, Kong F, et al: Oral contraceptive use and uterine leiomyoma risk: a meta-analysis based on cohort and case-control studies. Arch Gynecol Obstet 288(1):139, 2013
Reinhold C, McCarthy S, Bret PM, et al: Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation. Radiology 199(1):151, 1996
Rossetti A, Sizzi O, Soranna L, et al: Long-term results of laparoscopic myomectomy: recurrence rate in comparison with abdominal myomectomy. Hum Reprod 16(4):770, 2001
Sawin SW, Pilevsky ND, Berlin JA, et al: Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas. Am J Obstet Gynecology 183(6):1448, 2000
Sayed GH, Zakherah MS, El-Nashar SA, et al: A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia. Int J Gynaecol Obstet 112(2):126, 2011
Sayyah-Melli M, Mobasseri M, Gharabaghi PM, et al: Comparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression, a randomized clinical trial. Eur J Obstet Gynecol Reprod Biol 210:257, 2017
Scharla SH, Minne HW, Waibel-Treber S, et al: Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab 70(4):1055, 1990
Schlaff WD, Zerhouni EA, Huth JA, et al: A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata. Obstet Gynecol 74(6):856, 1989
Scialli AR, Levi AJ: Intermittent leuprolide acetate for the nonsurgical management of women with leiomyomata uteri. Fertil Steril 74(3):540, 2000
Setubal A, Alves J, Os?rio F, et al: Treatment for uterine isthmocele, a pouchlike defect at the site of a cesarean section scar. J Minim Invasive Gynecol 25(1):38, 2018
Shaaban OM, Ali MK, Sabra AM, et al: Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial. Contraception 92(4):301, 2015
Sharma K, Bora MK, Venkatesh BP, et al: Role of 3D ultrasound and Doppler in differentiating clinically suspected cases of leiomyoma and adenomyosis of uterus. J Clin Diagn Res 9(4):QC08, 2015
Sherer DM, Salame G, Shah T, et al: Transvaginal sonography of postabortal (Redo) syndrome. J Clin Ultrasound 39(3):155, 2011
Shiota M, Kotani Y, Umemoto M, et al: Deep-vein thrombosis is associated with large uterine fibroids. Tohoku J Exp Med 224(2):87, 2011
Socolov D, Blidaru I, Tamba B, et al: Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma. Eur J Contracept Reprod Health Care 16(6):480, 2011
Sommer EM, Balkwill A, Reeves G, et al: Effects of obesity and hormone therapy on surgically-confirmed fibroids in postmenopausal women. Eur J Epidemiol 30(6):493, 2015
Spies JB, Myers ER, Worthington-Kirsch R, et al: The FIBROID Registry: symptom and quality-of-life status 1 year after therapy. Obstet Gynaecol 106(6):1309, 2005
Spies JB, Spector A, Roth AR, et al: Complications after uterine artery embolization for leiomyomas. Obstet Gynecol 100(5 Pt 1):873, 2002
Stokes LS, Wallace MJ, Godwin RB, et al: Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomas. J Vasc Interv Radiol 21:1153, 2010
Surrey ES, Minjarez DA, Stevens JM, et al: Effect of myomectomy on the outcome of assisted reproductive technologies. Fertil Steril 83(5):1473, 2005
Tahara M, Shimizu T, Shimoura H: Preliminary report of treatment with oral contraceptive pills for intermenstrual vaginal bleeding secondary to a cesarean section scar. Fertil Steril 86(2):477, 2006
Takeuchi H, Kinoshita K: Evaluation of adhesion formation after laparoscopic myomectomy by systematic second-look microlaparoscopy. J Am Assoc Gynecol Laparosc 9(4):442, 2002
Templeman C, Marshall SF, Ursin G, et al: Adenomyosis and endometriosis in the California Teachers Study. Fertil Steril 90(2):415, 2008
Toor SS, Jaberi A, Macdonald DB, et al: Complication rates and effectiveness of uterine artery embolization in the treatment of symptomatic leiomyomas: a systematic review and meta-analysis. AJR Am J Roentgenol 199(5):1153, 2012
Traiman P, Saldiva P, Haiashi A, et al: Criteria for the diagnosis of diffuse uterine myohypertrophy. Int J Gynaecol Obstet 54(1):31, 1996
Tsujioka H, Matsuoka S, Sorano S, et al: Follow-up study of symptomatic submucous fibroids after hysteroscopic myomectomy. Clin Exp Obstet Gynecol 44(1):61, 2017
Tulandi T, Leung A, Jan N: Nonmalignant sequelae of unconfined morcellation at laparoscopic hysterectomy or myomectomy. J Minim Invasive Gynecol 23(3):331, 2016
Vercellini P, Crosignani PG, Mangioni C, et al: Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: results of a multicentre, randomised controlled trial. BJOG 105(11):1148, 1998
Vercellini P, Vigan? P, Somigliana E, et al: Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynaecol 20(4):465, 2006
Vervoort A, van der Voet LF, Hehenkamp W, et al: Hysteroscopic resection of a uterine caesarean scar defect (niche) in women with postmenstrual spotting: a randomised controlled trial. BJOG 125(3):326, 2018
Wamsteker K, Emanuel MH, de Kruif JH: Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension. Obstet Gynecol 82(5):736, 1993
Wise LA, Palmer JR, Spiegelman D, et al: Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology 16(3):346, 2005
Wise LA, Palmer JR, Stewart EA, et al: Polycystic ovary syndrome and risk of uterine leiomyomata. Fertil Steril 87(5):1108, 2007
Wishall KM, Price J, Pereira N, et al: Postablation risk factors for pain and subsequent hysterectomy. Obstet Gynecol 124(5):904, 2014
Yamamoto T, Noguchi T, Tamura T, et al: Evidence for estrogen synthesis in adenomyotic tissues. Am J Obstet Gynecol 169(3):734, 1993
Yan L, Ding L, Li C, et al: Effect of fibroids not distorting the endometrial cavity on the outcome of in vitro fertilization treatment: a retrospective cohort study. Fertil Steril 101(3):716, 2014
Yang C, Fang H, Yang Y, et al: Diagnosis and surgical management of inferior vena cava leiomyomatosis. J Vasc Surg Venous Lymphat Disord 6(5):636, 2018
Yang Z, Cao YD, Hu LN, et al: Feasibility of laparoscopic high-intensity focused ultrasound treatment for patients with uterine localized adenomyosis. Fertil Steril 91:2338, 2009
Yonehara Y, Yanazume S, Kamio M, et al: Concentrated ascites re-infusion therapy for pseudo-Meigs' syndrome complicated by massive ascites in large pedunculated uterine leiomyoma. J Obstet Gynaecol Res 40(7):1944, 2014
Yoo EH, Lee PI, Huh CY, et al: Predictors of leiomyoma recurrence after laparoscopic myomectomy. J Minim Invasive Gynecol 14(6):690, 2007
Youm J, Lee HJ, Kim SK, et al: Factors affecting the spontaneous expulsion of the levonorgestrel-releasing intrauterine system. Int J Gynaecol Obstet 126(2):165, 2014
Zaloudek C, Hendrickson M, Soslow RA: Mesenchymal tumors of the uterus. In Kurman RJ, Ellenson LH, Ronnett BM (eds): Blaustein’s Pathology of the Female Genital Tract, 6th ed. New York, Springer, 2011, p. 468
Zhang X, Li K, Xie B, et al: Effective ablation therapy of adenomyosis with ultrasound-guided high-intensity focused ultrasound. Int J Gynaecol Obstet 124(3):207, 2014
Zhang X, Yang M, Wang Q, et al: Prospective evaluation of five methods used to treat cesarean scar defects. Int J Gynaecol Obstet 134(3):336, 2016a
Zhang Y: A comparative study of transvaginal repair and laparoscopic repair in the management of patients with previous cesarean scar defect. J Minim Invasive Gynecol 23(4):535, 2016b
Adeyemi-Fowode O, Lin EG, Syed F, et al: Adnexal torsion in children and adolescents: a retrospective review of 245 cases at a single institution. J Pediatr Adolesc Gynecol 32(1):64, 2019
American College of Obstetricians and Gynecologists: Evaluation and management of adnexal masses. Practice Bulletin No. 174, November 2016
American College of Obstetricians and Gynecologists: The role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer in women at average risk. Committee Opinion No. 716, September 2017
American Society for Reproductive Medicine: Role of tubal surgery in the era of assisted reproductive technology: a committee opinion. Fertil Steril 103(6):e37, 2015
Archer DF, Carr BR, Pinkerton JV, et al: Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence. Menopause 22(7):786, 2015
Atri M, Alabousi A, Reinhold C, et al: ACR Appropriateness Criteria® clinically suspected adnexal mass, no acute symptoms. J Am Coll Radiol 16(5S):S77, 2019
Bider D, Mashiach S, Dulitzky M, et al: Clinical, surgical and pathologic findings of adnexal torsion in pregnant and nonpregnant women. Surg Gynecol Obstet 173(5):363, 1991
Black JD, Roque DM, Pasternak MC, et al: A series of malignant ovarian cancers arising from within a mature cystic teratoma: a single institution experience. Int J Gynecol Cancer 25(5):792, 2015
Camus E, Poncelet C, Goffinet F, et al: Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod 14(5):1243, 1999
Chalas E, Costantino JP, Wickerham DL, et al: Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial. Am J Obstet Gynecol 192(4):1230, 2005
Chen VW, Ruiz B, Killeen JL, et al: Pathology and classification of ovarian tumors. Cancer 97(S10):2631, 2003
Chiang AJ, Chen MY, Weng CS, et al: Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: a Taiwanese Gynecologic Oncology Group (TGOG) study. J Gynecol Oncol 28(5):e69, 2017
Cohen I, Potlog-Nahari C, Shapira J, et al: Simple ovarian cysts in postmenopausal patients with breast carcinoma treated with tamoxifen: long-term follow-up. Radiology 227(3):844, 2003
Cohen SB, Oelsner G, Seidman DS, et al: Laparoscopic detorsion allows sparing of the twisted ischemic adnexa. J Am Assoc Gynecol Laparosc 6(2):139, 1999
Comerci JT Jr, Licciardi F, Bergh PA, et al: Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature. Obstet Gynecol 84(1):22, 1994
Dalmau J, Gleichman AJ, Hughes EG, et al: Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091, 2008
Devouassoux-Shisheboran M, Silver SA, Tavassoli FA: Wolffian adnexal tumor, so-called female adnexal tumor of probable Wolffian origin (FATWO): immunohistochemical evidence in support of a Wolffian origin. Hum Pathol 30(7):856, 1999
Djavadian D, Braendle W, Jaenicke F: Laparoscopic oophoropexy for the treatment of recurrent torsion of the adnexa in pregnancy: case report and review. Fertil Steril 82(4):933, 2004
Dorum A, Blom GP, Ekerhovd E, et al: Prevalence and histologic diagnosis of adnexal cysts in postmenopausal women: an autopsy study. Am J Obstet Gynecol 192(1):48, 2005
Fan JT, Yan HQ, Malla S, et al: The clinical significance of CA19-9 in ovarian mature cystic teratoma. Clin Exp Obstet Gynecol 43(4):522, 2016
Fielder EP, Guzick DS, Guido R, et al: Adhesion formation from release of dermoid contents in the peritoneal cavity and effect of copious lavage: a prospective, randomized, blinded, controlled study in a rabbit model. Fertil Steril 65(4):852, 1996
Fuchs N, Smorgick N, Tovbin Y, et al: Oophoropexy to prevent adnexal torsion: how, when, and for whom? J Minim Invasive Gynecol 17(2):205, 2010
Genadry R, Parmley T, Woodruff JD: The origin and clinical behavior of the parovarian tumor. Am J Obstet Gynecol 129(8):873, 1977
Ghossain MA, Braidy CG, Kanso HN, et al: Extraovarian cystadenomas: ultrasound and MR findings in 7 cases. J Comput Assist Tomogr 29(1):74, 2005
Goldberg J, Pereira L, Berghella V, et al: Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol 191(1):18, 2004
Graif M, Shalev J, Strauss S, et al: Torsion of the ovary: sonographic features. AJR 143(6):1331, 1984
Grimes DA, Jones LB, Lopez LM, et al: Oral contraceptives for functional ovarian cysts. Cochrane Database Syst Rev 4:CD006134, 2014
Guttman PH Jr: In search of the elusive benign cystic ovarian teratoma: application of the ultrasound “tip of the iceberg” sign. J Clin Ultrasound 5(6):403, 1977
Hidalgo MM, Lisondo C, Juliato CT, et al: Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants. Contraception 73(5):532, 2006
Holt VL, Cushing-Haugen KL, Daling JR: Risk of functional ovarian cyst: effects of smoking and marijuana use according to body mass index. Am J Epidemiol 161(6):520, 2005
Hong S, Cui J, Li L, et al: Malignant female adnexal tumor of probable wolffian origin: case report and literature review. Int J Gynecol Pathol 37(4):331, 2018
Hoo W, Yazebek J, Holland T, et al: Expectant management of ultrasonically diagnosed ovarian dermoid cysts: is it possible to predict the outcome? Ultrasound Obstet Gynecol 36(2):235, 2010
Houry D, Abbott JT: Ovarian torsion: a fifteen-year review. Ann Emerg Med 38(2):156, 2001
Hyttel TE, Bak GS, Larsen SB, et al: Re-torsion of the ovaries. Acta Obstet Gynecol Scand 94(3):236, 2015
Jacobs I, Oram D, Fairbanks J, et al: A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. BJOG 97(10):922, 1990
Johnson NP, van Voorst S, Sowter MC: Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 1:CD002125, 2010
Kariminejad MH, Scully RE: Female adnexal tumor of probable Wolffian origin. A distinctive pathologic entity. Cancer 31(3):671, 1973
Karlsen MA, Sandhu N, H?gdall C, et al: Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass. Gynecol Oncol 127(2):379, 2012
Kim MJ, Kim NY, Lee DY, et al: Clinical characteristics of ovarian teratoma: age-focused retrospective analysis of 580 cases. Am J Obstet Gynecol 205(1):32.e1, 2011
Kives S, Gascon S, Dubuc E, et al: No. 341-diagnosis and management of adnexal torsion in children, adolescents, and adults. J Obstet Gynaecol Can 39:82, 2017
Kondo W, Bourdel N, Cotte B, et al: Does prevention of intraperitoneal spillage when removing a dermoid cyst prevent granulomatous peritonitis? BJOG 117(8):1027, 2010
Koonings PP, Campbell K, Mishell DR Jr, et al: Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 74(6):921, 1989
Korbin CD, Brown DL, Welch WR: Paraovarian cystadenomas and cystadenofibromas: sonographic characteristics in 14 cases. Radiology 208(2):459, 1998
Kurman RJ, Carcangiu ML, Herrington CS, et al (eds): WHO Classification of Tumours of Female Reproductive Organs, 4th ed. Lyon, International Agency for Research on Cancer, 2014
Lanes SF, Birmann B, Walker AM, et al: Oral contraceptive type and functional ovarian cysts. Am J Obstet Gynecol 166(3):956, 1992
Levine D, Brown DL, Andreotti RF, et al: Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement. Radiology 256(3):943, 2010
Li J, Ning Y, Abushahin N, et al: Secretory cell expansion with aging: risk for pelvic serous carcinogenesis. Gynecol Oncol 131(3):555, 2013
Linder D, McCaw BK, Hecht F: Parthenogenic origin of benign ovarian teratomas. N Engl J Med 292(2):63, 1975
Loutradis D, Stefanidis K, Kousidis I, et al: Effect of human hydrosalpinx fluid on the development of mouse embryos and role of the concentration of growth factors in culture medium with and without hydrosalpinx fluid. Gynecol Endocrinol 20(1):26, 2005
Lu S, Peng H, Zhang H, et al: Excessive intrauterine fluid cause aberrant implantation and pregnancy outcome in mice. PLoS One 8(10):e7844, 2013
Martinez-Onsurbe P, Ruiz VA, Sanz Anquela JM, et al: Aspiration cytology of 147 adnexal cysts with histologic correlation. Acta Cytol 45(6):941, 2001
Mashiach R, Melamed N, Gilad N, et al: Sonographic diagnosis of ovarian torsion: accuracy and predictive factors. J Ultrasound Med 30(9):1205, 2011
McGovern PG, Noah R, Koenigsberg R, et al: Adnexal torsion and pulmonary embolism: case report and review of the literature. Obstet Gynecol Surv 54(9):601, 1999
Medeiros LR, Rosa DD, Bozzetti MC, et al: Laparoscopy versus laparotomy for benign ovarian tumour. Cochrane Database Syst Rev 2:CD004751, 2009
Mehrad M, Ning G, Chen EY, et al: A pathologist’s road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube. Adv Anat Pathol 17(5):293, 2010
Michnovicz JJ, Hershcopf RJ, Naganuma H, et al: Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 315(21):1305, 1986
Milingos SD, Kallipolitis GK, Loutradis DC, et al: Laparoscopic treatment of hydrosalpinx: factors affecting pregnancy rates. J Am Assoc Gynecol Laparosc 7:355, 2000
Millar DM, Blake JM, Stringer DA, et al: Prepubertal ovarian cyst formation: 5 years’ experience. Obstet Gynecol 81(3):434, 1993
Moore RG, Jabre-Raughley M, Brown AK, et al: Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. Am J Obstet Gynecol 203(3):228.e1, 2010
Moore RG, McMeekin DS, Brown AK, et al: A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol 112(1):40, 2009
Moran O, Menczer J, Ben Baruch G, et al: Cytologic examination of ovarian cyst fluid for the distinction between benign and malignant tumors. Obstet Gynecol 82(3):444, 1993
Nahum GG, Kaunitz AM, Rosen K, et al: Ovarian cysts: presence and persistence with use of a 13.5 mg levonorgestrel-releasing intrauterine system. Contraception 91(5):412, 2015
Nardo LG, Kroon ND, Reginald PW: Persistent unilocular ovarian cysts in a general population of postmenopausal women: is there a place for expectant management? Obstet Gynecol 102(3):589, 2003
Nichols DH, Julian PJ: Torsion of the adnexa. Clin Obstet Gynecol 28(2):375, 1985
Okugawa K, Hirakawa T, Fukushima K, et al: Relationship between age, histological type, and size of ovarian tumors. Int J Gynaecol Obstet 74(1):45, 2001
Ory H: Functional ovarian cysts and oral contraceptives. Negative association confirmed surgically. A cooperative study. JAMA 228(1):68, 1974
Outwater EK, Mitchell DG: Normal ovaries and functional cysts: MR appearance. Radiology 198(2):397, 1996
Pantoja E, Rodriguez-Ibanez I, Axtmayer RW, et al: Complications of dermoid tumors of the ovary. Obstet Gynecol 45(1):89, 1975
Park JY, Kim DY, Kim JH, et al: Malignant transformation of mature cystic teratoma of the ovary: experience at a single institution. Eur J Obstet Gynecol Reprod Biol 141(2):173, 2008
Pascual MA, Graupera B, Pedrero C, et al: Long-term results for expectant management of ultrasonographically diagnosed benign ovarian teratomas. Obstet Gynecol 130(6):1244, 2017
Patel MD, Feldstein VA, Lipson SD, et al: Cystic teratomas of the ovary: diagnostic value of sonography. AJR 171(4):1061, 1998
Pauerstein CJ, Woodruff JD, Quinton SW: Development patterns in “adenomatoid lesions” of the fallopian tube. Am J Obstet Gynecol 100(7):1000, 1968
Peterson WF, Prevost EC, Edmunds FT, et al: Benign cystic teratomas of the ovary: a clinico-statistical study of 1,007 cases with a review of the literature. Am J Obstet Gynecol 70(2):368, 1955
Prat J: Ovarian serous and mucinous epithelial-stromal tumors. In Robboy SJ, Mutter GL, Prat J, et al (eds): Robboy’s Pathology of the Female Reproductive Tract, 2nd ed. Churchill Livingstone Elsevier, 2009, p 611
Rha SE, Byun JY, Jung SE, et al: CT and MR imaging features of adnexal torsion. Radiographics 22(2):283, 2002
Rody A, Jackisch C, Klockenbusch W, et al: The conservative management of adnexal torsion—a case-report and review of the literature. Eur J Obstet Gynecol Reprod Biol 101(1):83, 2002
Rossi BV, Ference EH, Zurakowski D, et al: The clinical presentation and surgical management of adnexal torsion in the pediatric and adolescent population. J Pediatr Adolesc Gynecol 25:109, 2012
Rousseau V, Massicot R, Darwish AA, et al: Emergency management and conservative surgery of ovarian torsion in children: a report of 40 cases. J Pediatr Adolesc Gynecol 21:201, 2008
Sagi-Dain L, Lavie O, Auslander R, et al: CA 19-9 in evaluation of adnexal mass: retrospective cohort analysis and review of the literature. Int J Biol Markers 30(3):e333, 2015
Salazar H, Kanbour A, Burgess F: Ultrastructure and observations on the histogenesis of mesotheliomas, “adenomatoid tumors,” of the female genital tract. Cancer 29(1):141, 1972
Schlaff WD, Hassiakos DK, Damewood MD, et al: Neosalpingostomy for distal tubal obstruction: prognostic factors and impact of surgical technique. Fertil Steril 54(6):984, 1990
Schorge JO, Modesitt SC, Coleman RL, et al: SGO white paper on ovarian cancer: etiology, screening and surveillance. Gynecol Oncol 119(1): 7, 2010
Simpkins F, Zahurak M, Armstrong D, et al: Ovarian malignancy in breast cancer patients with an adnexal mass. Obstet Gynecol 105(3):507, 2005
Strandell A, Lindhard A: Why does hydrosalpinx reduce fertility? The importance of hydrosalpinx fluid. Hum Reprod 17(5):1141, 2002
Strandell A, Lindhard A, Waldenstrom U, et al: Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod 14(11):2762, 1999
Suh-Burgmann E, Hung YY, Kinney W: Outcomes from ultrasound follow-up of small complex adnexal masses in women over 50. Am J Obstet Gynecol 211(6):623.e1, 2014
Suh-Burgmann E, Kinney W: Potential harms outweigh benefits of indefinite monitoring of stable adnexal masses. Am J Obstet Gynecol 213(6):816.e1, 2015
Timmerman D, Testa AC, Bourne T, et al: Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol 23:8794, 2005
Timmerman D, Valentin L, Bourne T, et al: Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group. Ultrasound Obstet Gynecol 16:500, 2000
Timmerman D, Van Calster B, Testa A, et al: Predicting the risk of malignancy in adnexal masses based on the simple rules from the International Ovarian Tumor Analysis group. Am J Obstet Gynecol 214:424, 2016
Twickler DM, Forte TB, Santos-Ramos R, et al: The Ovarian Tumor Index predicts risk for malignancy. Cancer 86:2280, 1999
Ueland FR, Desmone CP, Seamon LG, et al: Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors. Obstet Gynecol 117(6):1289, 2011
Vuento MH, Pirhonen JP, Makinen JI, et al: Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound. Cancer 76(7):1214, 1995
Ware Miller R, Smith A, DeSimone CP, et al: Performance of the American College of Obstetricians and Gynecologists’ ovarian tumor referral guidelines with a multivariate index assay. Obstet Gynecol 117(6):1298, 2011
Warner MA, Fleischer AC, Edell SL, et al: Uterine adnexal torsion: sonographic findings. Radiology 154(3):773, 1985
Weitzman VN, DiLuigi AJ, Maier DB, et al: Prevention of recurrent adnexal torsion. Fertil Steril 90(5):2018.e1, 2008
Whiteman MK, Kuklina E, Jamieson DJ, et al: Inpatient hospitalization for gynecologic disorders in the United States. Am J Obstet Gynecol 202(6):541.e1, 2010
Wyshak G, Frisch RE, Albright TE, et al: Smoking and cysts of the ovary. Int J Fertil 33(6):398, 1988
Yan B, Wang Y, Zhang Y, et al: Teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis: a case report and literature review. Medicine (Baltimore) 98(21):e15765, 2019
Zeyneloglu HB, Arici A, Olive DL: Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization-embryo transfer. Fertil Steril 70(3):492, 1998
Zweizig S, Perron J, Grubb D, et al: Conservative management of adnexal torsion. Am J Obstet Gynecol 168(6 Pt 1):1791, 1993
Труды отечественных авторов при подготовке статей по гинекологии для пользователей сайта - не использовались, так как их вы всегда можете найти в библиотеках.
